(redirected from Fosphenytoin sodium)
Also found in: Medical.


 (fŏs′fĕn′ĭ-tō′ĭn, -fə-nĭt′ō-)
A prodrug that is metabolized to phenytoin and administered parenterally for the treatment of seizures.

[Alteration of phos(phorus) + phenytoin.]
References in periodicals archive ?
Pharmaceutical company Mylan NV (TASE:MYL) stated on Thursday that it has introduced Fosphenytoin Sodium Injection USP, 75 mg/ml, (50 mg PE/ml) in the US market
Fosphenytoin sodium was approved for intravenous (IV) or intramuscular (IM) administration in the treatment of SE, as well as for the prevention or treatment of seizures in patients who cannot take oral AEDs.
Fosphenytoin sodium (Cerebyx[R]) - Parke-Davis) is a new drug developed specifically to replace intravenous phenytoin sodium (Dilantin[R] - Parke-Davis).
The Joint Venture has now placed purchase orders for five Injectable ANDA products, one for Fosphenytoin Sodium, two for Ondansetron, one for Flumazenil and one for an expected ANDA approval in the near term.
NEW YORK -- Amneal Biosciences, a unit of Amneal Pharmaceuticals LLC, has launched its first product: generic fosphenytoin sodium injection.
Akorn-Strides, LLC today announced the approval of an ANDA for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL (equivalent to Phenytoin Sodium).
Wockhardt now markets 21 generic products in oral solid and injectable dosage forms, including Ceftriaxone for Injection, Clarithromycin Tablets, Fosphenytoin Sodium Injection and Zolpidem Tablets.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fosphenytoin Sodium Injection, 100 mg, 2 mL and 500 mg, 10 mL vials, USP, the generic equivalent of Pfizer's Cerebyx([R]).
After the close of the first quarter, the company received an Abbreviated New Drug Application (ANDA) approval for Clindamycin Injection and a tentative approval for Fosphenytoin Sodium Injection from the U.
Fosphenytoin Sodium Injection can be used for the control of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery.
FDA approval for its abbreviated new drug application for fosphenytoin sodium to become final in Aug.
Food and Drug Administration has granted tentative approval for the Company's ANDA for Fosphenytoin Sodium Injection USP, 50 mg PE/mL (PE = phenytoin sodium equivalents).